EVOLVEIMMUNE THERAPEUTICS INC
–
Branford Center, CT, 06405
... Our lead asset, EVOLVE104, is anticipated to enter clinical trials in mid-2025. EvolveImmune’s team consists of over 45 FTEs in R&D, business development and operations with immediate plans for additional growth. Our newly expanded, state-of-the-art ... - May 19